Co-Authors
This is a "connection" page, showing publications co-authored by Massimo Andreoni and Federico Pea.
Connection Strength
0.294
-
The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives. Expert Rev Anti Infect Ther. 2021 09; 19(9):1125-1134.
Score: 0.234
-
Real-World Use of Dalbavancin in the Era of Empowerment of Outpatient Antimicrobial Treatment: A Careful Appraisal Beyond Approved Indications Focusing on Unmet Clinical Needs. Drug Des Devel Ther. 2021; 15:3349-3378.
Score: 0.060